|
Drugs to treat depression
| |
|
Antidepressant
|
60.9%
|
|
Selective serotonin reuptake inhibitors (SSRI)
|
(43.5%)
|
|
Antidepressant tretracyclics
|
(8.7%)
|
|
Serotonin and noradrenaline reuptake inhibitors
|
(4.3%)
|
|
Other antidepressants
|
(4.3%)
|
|
Anxiolytics
|
30.4%
|
|
Benzodiazepines
|
(26.1%)
|
|
Other anxiolytics
|
(4.3%)
|
|
Hypnotic-sedatives
|
4.3%
|
|
Drugs to treat anxiety
| |
|
Anxiolytics
|
60.9%
|
|
Benzodiazepines
|
(56.5%)
|
|
Other anxiolytics
|
(4.3%)
|
|
Antidepressants
|
34.8%
|
|
Selective serotonin reuptake inhibitors (SSRI)
|
(26.1%)
|
|
Serotonin and noradrenaline reuptake inhibitors
|
(8.7%)
|
|
Hypnotic-sedatives
|
4.3%
|
|
Other hypnotic-sedatives
|
(4.3%)
|
|
Drugs to treat insomnia
| |
|
Anxiolytics
|
35.7%
|
|
Benzodiazepines
|
(35.7%)
|
|
Hypnotic-sedatives
|
(35.7%)
|
|
Benzodiazepines
|
(2.9%)
|
|
Melatonin receptor agonists
|
(3.6%)
|
|
Imidazopyridines
|
(5.9%)
|
|
Other hypnotic-sedatives
|
(17.9%)
|
|
Antidepressants
|
10.7%
|
|
Selective serotonin reuptake inhibitors (SSRI)
|
(3.6%)
|
|
Tricyclic antidepressants (TCAs)
|
(7.1%)
|
|
Drugs to relax and calm down (tranquilizers)
| |
|
Anxiolytics
|
42.6%
|
|
Benzodiazepines
|
(42.6%)
|
|
Hypnotic-sedative
|
35.7%
|
|
Benzodiazepines
|
(2.9%)
|
|
Imidazopyridines
|
(5.9%)
|
|
Other hypnotic-sedatives
|
(17.6%)
|
|
Anti-inflammatory and analgesic drugs
|
20.6%
|
|
Antidepressants
|
2.9%
|
|
Selective serotonin reuptake inhibitors (SSRI)
|
(1.5%)
|
|
Serotonin and noradrenaline reuptake inhibitors
|
(1.4%)
|
